Obesity-related abnormal eating behaviors in Type 2 diabetic patients

• Published in: Pakistan journal of medical sciences Vol. 29; no. 6; pp. 1323 - 1328
• Main Authors: Ercan, Aydan, Kiziltan, Gul
• Format: Journal Article
• Language: English
• Published: Pakistan Knowledge Bylanes 01.11.2013; AsiaNet Pakistan (Pvt) Ltd; Professional Medical Publicaitons
• Subjects: Analysis; Body mass index; Body weight; Compulsive eating; Diabetes; Diabetics; Food habits; Obesity; Original; United Kingdom; Obesity; Binge eating; Type 2 diabetes mellitus; Eating behaviors; Night eating
• ISSN: 1682-024X; 1681-715X
• DOI: 10.12669/pjms.296.3657

To determine the obesity-related abnormal eating behaviors in Type 2 diabetic patients. It was a cross-sectional study involving 120 Type 2 diabetic patients. Body weight and height of the individuals were measured and body mass index (BMI) was calculated. Bulimic Investigatory Test-Edinburg (BITE) was used to measure binge eating attitudes. Night eating symptoms were defined as consuming >25% of daily energy after suppertime. To determine the glycaemic control, HbA1c levels were analyzed. Data analyzed by SPSS 13.0 for Windows. The mean age of the patients was 55.3±9.29 years. The mean diabetes duration was 11.1±2.04 years. The 50% of the patients had a BMI higher than 25kg/m(2). The obese diabetic patients were more likely to have diabetic complications than non-obese subjects (x (2) = 8.588, p=0.040). The percentages of the diabetic patients who met the criteria for binge eating and night eating were 17.2% and 42% respectively. Half of the patients were skipping a main meal per day. The frequencies of obesity-related abnormal eating behaviors were not statistically different in obese patients versus non-obese participants (p>0.05). The mean HbA1c levels were higher in diabetic patients than biochemical references and there was a significant difference between obese and non-obese patients (p<0.05). Obesity-related abnormal eating behaviors were prevalent in Type 2 diabetic patients and related with diabetic complications and glycaemic control.